Close Menu

USPTO

A US federal district court in Utah denied Myriad Genetics and other plaintiffs a preliminary junction that would have stopped Ambry Genetics from selling competing BRCA tests, even though the court determined this may harm Myriad's business.

Title: siRNA Compositions and Methods for Potently Inhibiting Viral Infection
Patent Number: 8,664,188
Filed: Dec. 11, 2009

Title: Drug Carrier and Drug Carrier Kit for Inhibiting Fibrosis
Patent Number: 8,652,526
Filed: April 4, 2012

NEW YORK (GenomeWeb News) – Genetic Technologies announced today it received a further ex parte re-examination certificate from the US Patent and Trademark Office for certain claims related to the company's non-coding DNA patent.

Title: Prevention of Chlamydia Infection using siRNA
Patent Number: 8,648,052
Filed: Oct. 8, 2007

Title: Lipid-containing Formulations
Patent Number: 8,642,076
Filed: Aug. 16, 2011

Title: Apoptotic Cell-mediated Transfection of Mammalian Cells with Interfering RNA
Patent Number: 8,637,476

Title: RNA Sequence-specific Mediators of RNA Interference
Patent Number: 8,632,997
Filed: Oct. 4, 2010

Title: Detection of Small Nucleic Acids
Patent Number: 8,609,336
Filed: Feb. 7, 2012

Title: Methods for Diagnosing Breast Cancer Using microRNAs

Pages

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.